News

Corteria Pharmaceuticals team is growing with the arrival of two very valuable members: Eléonore Jouanny who will be in charge of the CMC activities of our assets and Stephane Durant des Aulnois who is our new CFO…
Francesca is a physician with 30+ years’ experience in drug development encompassing phase 1 through phase 3 registrational trials and life cycle management. Her specialized expertise is in cardio-metabolic diseases. She joined Corteria from Applied Therapeutics, a clinical-stage biotechnology company, where, as the Head of Development and later VP, Clinical and Regulatory Strategy, she
Corteria Pharmaceuticals announces closing of €12M seed financing to advance portfolio assets.